Latest news
Loading news…
Nobias Therapeutics is a developer of small molecule drugs to treat pediatric diseases.
Nobias Therapeutics was acquired by Synaptiq Therapeutics in 2026.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Philadelphia, Pennsylvania, United States
2
professional contacts at Nobias Therapeutics
Contact execs at Nobias Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Nobias Therapeutics
Loading news…
FAQs about Nobias Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.